Karina Eurídice Juárez-Mercado (Hassan Villegas-Quintero, K Eurídice Juárez-Mercado)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Emergency Department

Molecular Docking

Dna Methylation

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

K Eurídice Juárez-Mercado, Juan F Avellaneda-Tamayo, Karina Eurídice Juárez-Mercado, Ana L Chávez-Hernández, Claudia Daniela López-López, José Luis Medina-Franco
Food Chemicals and Epigenetic Targets: An Epi Food Chemical Database. ACS omega 9 (23) (2024)
K Eurídice Juárez-Mercado, Juan F Avellaneda-Tamayo, Karina Eurídice Juárez-Mercado, Ana L Chávez-Hernández, Claudia Daniela López-López, José Luis Medina-Franco
Food Chemicals and Epigenetic Targets: An Epi Food Chemical Database. ACS omega 9 (23) (2024)
Karina Eurídice Juárez-Mercado, Milton Abraham Gómez-Hernández, Juana Salinas-Trujano, Luis Córdova-Bahena, Clara Espitia, Sonia Mayra Pérez-Tapia, José Luis Medina-Franco, Marco Antonio Velasco Velazquez
Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Karina Eurídice Juárez-Mercado, Milton Abraham Gómez-Hernández, Juana Salinas-Trujano, Luis Córdova-Bahena, Clara Espitia, Sonia Mayra Pérez-Tapia, José Luis Medina-Franco, Marco Antonio Velasco Velazquez
Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Ana L Chávez-Hernández, Karina Eurídice Juárez-Mercado, Fernanda I Saldívar-González, José Luis Medina-Franco
Towards the De Novo Design of HIV-1 Protease Inhibitors Based on Natural Products. Biomolecules 11 (12) (2021)
Karina Eurídice Juárez-Mercado, Fernando D Prieto-Martínez, Norberto Sánchez-Cruz, Andrea Peña-Castillo, Diego Prada-Gracia, José Luis Medina-Franco
Expanding the Structural Diversity of DNA Methyltransferase Inhibitors. Pharmaceuticals (Basel, Switzerland) 14 (1) (2020)